Position in BIIB
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,877,412
+$587,372 QoQ
Shares Held
17,946
0.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#273
of 1,036 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kintegral Advisory, LLC holds $82,893,440 across 8 Drug Manufacturers - General names. BIIB ranks #7 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,208 | $18,240,932 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
115,097 | $14,541,354 | |
| 3 | ABBV |
AbbVie Inc.
|
52,394 | $13,184,426 | |
| 4 | MRK |
Merck & Co., Inc.
|
91,933 | $11,813,390 | |
| 5 | AMGN |
Amgen Inc
|
29,489 | $10,678,556 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
116,111 | $6,690,315 | |
| 7 | BIIB |
Biogen Inc.
This page
|
17,946 | $3,877,412 | |
| 8 | PFE |
Pfizer Inc
|
160,592 | $3,867,055 |
All Filings in BIIB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,877,412 | 17,946 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $3,290,040 | 17,946 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,298,404 | 18,742 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $2,697,100 | 19,254 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $2,428,910 | 19,340 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $2,650,453 | 19,369 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $2,972,000 | 19,435 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $3,942,705 | 20,340 | Shares | Defined | 2024-11-04 | |
| 2024-06-30 | $4,776,882 | 20,606 | Shares | Defined | 2024-07-26 | |
| 2024-03-31 | $2,743,029 | 12,721 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $3,302,163 | 12,761 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $3,660,322 | 12,850 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $3,572,685 | 12,850 | Shares | Defined | 2023-04-27 | |
| 2022-12-31 | $3,749,496 | 13,540 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,210,226 | 8,278 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $1,688,215 | 8,278 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $1,706,491 | 8,103 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,900,406 | 7,921 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,241,563 | 7,921 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $2,742,804 | 7,921 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,215,899 | 7,921 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,939,536 | 7,921 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,247,029 | 7,921 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,187,488 | 8,176 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,586,722 | 8,176 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||